This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): ALGRX 1207
Description: 1207 is a topical, local anesthetic that binds to the fast sodium channel on both A nerve fibers responsible for transmitting immediate adaptive pain signals and C nerve fibers responsible for transmitting longer-term, dull, aching throbbing pain signals. By interrupting the communication channel of both A fibers and C fibers, 1207 is designed to provide effective topical pain relief with a quick onset and long duration of action.
Deal Structure: 1207 was originally developed by Anesiva.
In August 2009, Anesiva and Arcion Therapeutics announced the signing of a definitive merger agreement.
In December 2009, Anesiva announced that it was unable to satisfy the closing conditions set forth in the Agreement and Plan of Merger with Arcion Therapeutics. Anesiva intends to immediately cease operations and to file a petition for relief under the Bankruptcy Code.
Additional information available to subscribers only: